Everest Medicines expands Asia-Pacific presence with licensing deal for Bejescin
Exclusive Asia-Pacific licensing agreement for Bejescin strengthens the company’s nephrology and autoimmune disease portfolio
Exclusive Asia-Pacific licensing agreement for Bejescin strengthens the company’s nephrology and autoimmune disease portfolio
The greenfield facility in Madhya Pradesh expected to create up to 500 direct jobs, in addition to generating indirect employment opportunities
The agreement underscores Roche’s commitment to advancing innovative therapies for blood cancers and other serious diseases
The program expected to commence in August 2026 will be offered across multiple specialised areas with an intake of 20-30 students per course
The webinar on World Environment Day brought together scientists, policymakers, industry representatives, and researchers to discuss the role of biotech and biomanufacturing in addressing climate change and advancing sustainable development
Exclusive partnership to expand access to high-quality seamless anodized aluminium packaging for sterile APIs and pharmaceutical products across India.
Multi-target licensing agreement combines Stipple Bio’s epitope discovery platform with Lonza’s ADC technologies to develop targeted cancer treatments
MSD joins as anchor customer as Aurobindo strengthens its position in the fast-growing global biologics manufacturing market
Teva said the launch strengthens its biosimilars strategy and expands access to biologic medicines across Europe
Dr. Jain brings extensive experience in the biotech and pharma sectors and has been instrumental in driving innovation, vaccine development, and healthcare advancement
Subscribe To Our Newsletter & Stay Updated